Cancerogenicità dei farmaci antiblastici, classificazioni, protezione e prevenzione, utilizzo ed evidenze

Translated title of the contribution: Carcinogenicity of antineoplastic drug: VSE, toxicity, classification, prevention and protection measures

Pietro Apostoli, Simona Catalani, Roberto Bergonzi, Carla Galloni, Martina Minguzzi

Research output: Contribution to journalArticle

Abstract

Many antineoplastic agents have been shown to be mutagenic, teratogenic and carcinogenic in experimental studies and secondary malignant neoplasms are known to be associated with several specific therapeutic treatments. However, the occupational exposure to antineoplastic drugs in health care workers has different routes of exposure, dose and duration compared lo patients undergoing treatment protocols. The aims of this review are to analyze and to update the National and International Classification, and deepening the topics of occupational exposure, current operating conditions, the technical and operational progress to reducing the exposure, the epidemiological evidence and exposure measurement data available. Finally, we illustrate the dispersion in the environment as a real risk for the general population.

Translated title of the contributionCarcinogenicity of antineoplastic drug: VSE, toxicity, classification, prevention and protection measures
Original languageItalian
Pages (from-to)5-16
Number of pages12
JournalGiornale Italiano di Medicina del Lavoro ed Ergonomia
Volume36
Issue number1
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Carcinogenicity of antineoplastic drug: VSE, toxicity, classification, prevention and protection measures'. Together they form a unique fingerprint.

  • Cite this